Detalhe da pesquisa
1.
Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin-deficient and mdx mice.
J Cachexia Sarcopenia Muscle
; 13(1): 544-560, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927367
2.
Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B.
PLoS One
; 14(8): e0220903, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31404091